when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

CYCLE · news · pharmadog

← back to CYCLE

News mentioning CYCLE

96 stories

Sep 16, 26Sling catches $123M series C for thyroid eye disease pillbiospace

Sep 15, 26Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meetingbiospace

Sep 8, 26Opinion: It’s time to take the gloves off during vaccinationstat

Sep 8, 26STAT+: UnitedHealth executives shower high-ranking Democrat with donations ahead of midtermsstat

Sep 8, 26Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durabilityfiercebiotech

Sep 3, 26Biopharma needs more data scientists. Who's getting hired?biospace

Sep 2, 26Follow the money: How funding announcements can help identify jobs before they’re postedbiospace

Sep 2, 26UniQure files for FDA, UK approval of first gene therapy for Huntington’s diseasebiospace

Sep 2, 26Opinion: The next DSM should address the algorithm’s role in eating disordersstat

Sep 2, 26Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial failsbiospace

Sep 1, 26Opinion: I’m a reproductive psychiatrist. The Lindsay Clancy trial will cause terrible damage to my fieldstat

Sep 1, 26Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?fiercebiotech

Sep 1, 26STAT+: Will House delay Trump plan to politicize NIH grants?stat

Aug 31, 26Takeda, Protagonist score broad FDA nod in rare blood cancer, setting up $2B opportunitybiospace

Aug 27, 26Hospitals are plotting a long-shot push to roll back $1 trillion in Medicaid cutsstat

Aug 25, 26Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten reboundbiospace

Aug 20, 26Opinion: The global health aid architecture is collapsing. The faith economy isn’tstat

Aug 18, 26STAT+: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firmstat

Aug 17, 26FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vaxbiopharma dive

Aug 14, 26BMS welcomes new multiple myeloma drug as generics batter current portfoliobiospace

Aug 13, 26PDUFA VIII: FDA outlines goals, program enhancements in commitment letterraps

Aug 12, 26With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug developmentbiospace

Aug 11, 26Building Resilience for the Future of Biopharma Innovationfiercebiotech

Aug 10, 26Regulatory operations: The overlooked half of submission readinessbiopharma dive

Aug 7, 26Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attackstat

Aug 6, 26STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and morestat

Aug 5, 264 potential biotech M&A targets, plus a pretty sure bet from J&Jbiospace

Aug 4, 26Opinion: I’m using not-FDA-approved software to manage my diabetes. I’ve never felt betterstat

Jul 30, 26J&J pays Sail $785M, charting course to possible in vivo CAR-T buyoutfiercebiotech

Jul 30, 26Recon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drugraps

← prevpage 2 of 4next →